J3KA Stock Overview
Atmofizer Technologies Inc. researches, develops, designs, manufactures, and sells air purification devices in Canada and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Atmofizer Technologies Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.035 |
| 52 Week High | CA$0.089 |
| 52 Week Low | CA$0.0005 |
| Beta | -0.49 |
| 1 Month Change | 5.97% |
| 3 Month Change | -2.74% |
| 1 Year Change | -47.79% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.96% |
Recent News & Updates
Recent updates
Shareholder Returns
| J3KA | DE Machinery | DE Market | |
|---|---|---|---|
| 7D | 7.6% | 0.6% | 1.1% |
| 1Y | -47.8% | 23.7% | 6.5% |
Return vs Industry: J3KA underperformed the German Machinery industry which returned 22.9% over the past year.
Return vs Market: J3KA underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| J3KA volatility | |
|---|---|
| J3KA Average Weekly Movement | 336.7% |
| Machinery Industry Average Movement | 4.1% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: J3KA's share price has been volatile over the past 3 months.
Volatility Over Time: J3KA's weekly volatility has increased from 177% to 337% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 4 | Olivier Centner | www.atmofizer.com |
Atmofizer Technologies Inc. researches, develops, designs, manufactures, and sells air purification devices in Canada and the United States. The company offers Atmofizer One that reduces airborne viruses and bacteria in treated air, as well as neutralize ultra-fine particulates. The company provides air purification devices for smaller commercial rooms, larger commercial spaces, and consumer use.
Atmofizer Technologies Inc. Fundamentals Summary
| J3KA fundamental statistics | |
|---|---|
| Market cap | €380.26k |
| Earnings (TTM) | -€944.46k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.5x
P/E RatioIs J3KA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| J3KA income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$22.75k |
| Gross Profit | -US$22.75k |
| Other Expenses | US$999.29k |
| Earnings | -US$1.02m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.12 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -20.9% |
How did J3KA perform over the long term?
See historical performance and comparison